Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
It belongs to a novel class of agents known as triple agonists, targeting three incretin and metabolic receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
It acts through the GHS-R, a different receptor than CJC-1295 (which targets the GHRH receptor), which is why the two are commonly studied together
It is not intended for human therapeutic, diagnostic, or clinical use.
If the ulcer is small, there may be few symptoms
US$ 28.19
US$ 28.11
US$ 20.63
US$ 23.17
US$ 21.59
US$ 27.30
US$ 26.98
US$ 28.28
